Introduction

The “Alpine Winter Conference on Medicinal and Synthetic Chemistry” exposes attending scientists to cutting edge synthetic and medicinal chemistry as well as latest developments in technologies that foster innovation in drug discovery.

The main target audience for this highly interdisciplinary meeting will include medicinal and synthetic chemists, as well as related drug discovery disciplines from both industry and academia as well as graduate/undergraduate students and postdocs.

In the spirit of Keystone and Gordon conferences as well as the MBCF (Medicinal and Bioorganic Chemistry Foundation) conference in Steamboat Springs, the format of this meeting provides ample opportunity for attendees to informally interact. The aim is to strengthen existing networks and create new contacts.

The Conference topics will include:

• Antiviral Drug Discovery
• Cryo-EM: Applications for Structure-Based Drug Discovery
• Drug Discovery Tales 1 & 2
• From Underground to Mainstream: Neglected and Novel, Emerging Functional Groups for Drug Discovery
• Human Dose Prediction in the Discovery Space
• Latest Advances and Approaches in Bioconjugation Drug Discovery
• Radical Intermediates in Complex Molecule Synthesis
• Recent Developments in Synthetic Methodologies and their Impact

Deadlines

• Oct 25 2023
  Oral abstracts deadline

  
• Oct 25 2023
  Early bird registration deadline

  
• Nov 25 2023
  Poster abstract deadline

  

Useful links

• Further event details More information about the event

Speakers

• Prof. Benjamin LIST MAX PLANCK INSTITUTE, Muelheim an der Ruhr, Germany
• Dr Dafydd OWEN PFIZER, Cambridge, United States
• Prof. M. Christina WHITE UNIVERSITY OF ILLINOIS URBANA-CHAMPAIGN, Urbana, United States
• Prof. Bhaskar DAS LONG ISLAND UNIVERSITY, Brooklyn, United States
• Dr Yoshihiro ISHIHARA VIVIDION THERAPEUTICS, San Diego, United States
• Prof. Tracey PIRALI UNIVERSITY OF PIEMONTE ORIENTALE, Novara, Italy
• Prof. Michael WILLIS UNIVERSITY OF OXFORD, Oxford, United Kingdom
• Dr Johan BYLUND CTC CLINICAL TRIAL CONSULTANTS AB, Uppsala, Sweden
• Dr Gregori GEREBTZOFF NOVARTIS INSTITUTES FOR BIOMEDICAL RESEARCH, Basel, Switzerland
• Dr Andres OLIVARES F. HOFFMANN-LA ROCHE, Basel, Switzerland
• Prof. Daniele LEONORI RWTH AACHEN UNIVERSITY, Aachen, Germany
• Prof. Bill MORANDI ETH ZÜRICH, Zürich, Switzerland
• Prof. Cristina NEVADO UNIVERSITY OF ZURICH, Zurich, Switzerland
• Prof. Ryan SHENVI SCRIPPS RESEARCH, La Jolla, United States
• Prof. Kazuhiro ABE NAGOYA UNIVERSITY, Aichi, Japan
• Dr Rebecca EBENHOCH BOEHRINGER INGELHEIM, Biberach, Germany
• Prof. Jonathan F. FAY UNIVERSITY OF NORTH CAROLINA CHAPEL HILL, Chapel Hill, United States
• Dr Harini KRISHNAMURTHY MERCK, SHARP & DOHME, Blue Bell, United States
• Dr Niginia BORLINGHAUS UNIVERSITY OF KONSTANZ, Konstanz, Germany
• Dr Josep CORNELLA COSTA MAX PLANCK INSTITUTE FOR COAL RESEARCH, Mülheim an der Ruhr, Germany
• Prof. Timothy NOËL UNIVERSITY OF AMSTERDAM, Amsterdam, Netherlands
• Prof. Francesca PARADISI UNIVERSITY OF BERN, Bern, Switzerland
• Dr Helmut BUSCHMANN AICURIS ANTI-INFECTIVE CURES GMBH, Wuppertal, Germany
• Dr Dimitar GOTCHEV ARBUTUS BIOPHARMA, Doylestown, United States
• Prof. Priscilla YANG STANFORD UNIVERSITY, Stanford, United States
• Dr Mark FRIGERIO BICYCLE THERAPEUTICS, Cambridge, United Kingdom
• Prof. Christian HACKENBERGER FMP BERLIN, Berlin, Germany

---

Sponsorship & supporting organisations

---

Sponsors

EFMC

Venue

Arlberg WellCom

Arlberg WellCom, Hannes-Schneider-Weg 11, St. Anton am Arlberg, 6580, Austria

Committee

• Dr Klemens HOEGENAUER Novartis Institutes for BioMedical Research, Basel, Switzerland
• Dr Karl Heinz KRAWINKLER Novartis Global Drug Development, Basel, Switzerland
• Dr Antonia F. STEPAN F. Hoffmann-La Roche Ltd, Basel, Switzerland

---

Organised by

International Forum for Biomedical Research (IFBR)
The scientific content of the event is brought to the audience by the Association: International Forum for Biomedical Research (IFBR). 

The association fulfills the following purpose in a non-profit manner and with no economic objectives:

• Establishment and operation of a forum in Switzerland to promote research in the biomedical field, in particular, for interdisciplinary cooperation in these areas.
• Strengthening the network between researchers from all countries, especially between chemists in the medicinal and synthetic fields.
• Promotion of the international exchange of research results.
• Provision of a platform for the joint processing of research projects.
• Promotion of young researchers in the field of biomedicine who are mainly active in Switzerland, for example by awarding sponsorship awards.
• Preparation, editing and support of publications.
• Implementation and support of the organization of international conferences, in particular the "Alpine Winter Conference on Medicinal and Synthetic Chemistry".

Contact information

Bernard Dacier
LD Organisation
Contact us by email

---